abrdn Life Sciences Investors
€14.93
EUR
Last updated on --.
24h volume94.55K
24h highest14.9390 EUR
24h lowest14.7937 EUR
24h Price movement+1.05%
HQL recent prices
24 Hours
+1.05%+€0.15473
30 days
-1.37%-€0.2063
60 days
+7.10%+€0.97994
90 days
+4.09%+€0.58453
Key data
Previous close14.7765 EUR
Market cap461.61M EUR
Volume94.55K
P/E ratio--
Dividend yield (TTM)--
Dividend amount0.48138 EUR
Next ex-dividend date21 May 2026
Next payment date30 June 2026
EPS diluted (TTM)--
Net income (FY)--
Revenue (FY)--
Last report date--
About abrdn Life Sciences Investors
Listed onNew York Stock Exchange
HQL conversion tables
 |  |
|---|---|
| 0.5 HQL | 7.465 EUR |
| 1 HQL | 14.93 EUR |
| 5 HQL | 74.65 EUR |
| 10 HQL | 149.31 EUR |
| |
|---|---|
| 0.5 EUR | 0.033487 HQL |
| 1 EUR | 0.066974 HQL |
| 5 EUR | 0.33487 HQL |
| 10 EUR | 0.66974 HQL |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
HQL is trading at €14.93, +1.05% over the last 24 hours. Track live moves on the price chart at the top of this page.
The HQL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HQL is currently trading at €14.93, +1.05% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HQL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HQL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HQL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HQL's historical range and other companies in the sector.
abrdn Life Sciences Investors's market cap is currently 461.61M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume94.55K
24h highest14.9390 EUR
24h lowest14.7937 EUR
24h Price movement+1.05%
Start trade with HQL Perpetual
Sign up to trade